- call +1-201-465-4211
- email sales@mrinsights.biz
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Scope of the Report:
This report focuses on the Anti-depressant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
The worldwide market for Anti-depressant Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
ALKERMES PLC
ALLERGAN PLC
BRISTOL MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
GLAXOSMITHKLINE INC.
H. LUNDBECK A/S
MERCK INC.
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL INC.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market Segment by Applications, can be divided into
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
There are 15 Chapters to deeply display the global Anti-depressant Drugs market.
Chapter 1, to describe Anti-depressant Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-depressant Drugs, with sales, revenue, and price of Anti-depressant Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-depressant Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-depressant Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-depressant Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-depressant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Tricyclic Antidepressants
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitors
1.2.4 Monoamine Oxidase Inhibitors
1.2.5 Serotonin Antagonist
1.2.6 Reuptake Inhibitors
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Major Depressive Disorder
1.3.2 Obsessive-Compulsive Disorder
1.3.3 Generalized Anxiety Disorder
1.3.4 Panic Disorder
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ALKERMES PLC
2.1.1 Business Overview
2.1.2 Anti-depressant Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ALKERMES PLC Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ALLERGAN PLC
2.2.1 Business Overview
2.2.2 Anti-depressant Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ALLERGAN PLC Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 BRISTOL MYERS SQUIBB COMPANY
2.3.1 Business Overview
2.3.2 Anti-depressant Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BRISTOL MYERS SQUIBB COMPANY Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 ELI LILLY AND COMPANY
2.4.1 Business Overview
2.4.2 Anti-depressant Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ELI LILLY AND COMPANY Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GLAXOSMITHKLINE INC.
2.5.1 Business Overview
2.5.2 Anti-depressant Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GLAXOSMITHKLINE INC. Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 H. LUNDBECK A/S
2.6.1 Business Overview
2.6.2 Anti-depressant Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 H. LUNDBECK A/S Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 MERCK INC.
2.7.1 Business Overview
2.7.2 Anti-depressant Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MERCK INC. Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 PFIZER INC.
2.8.1 Business Overview
2.8.2 Anti-depressant Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PFIZER INC. Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
2.9.1 Business Overview
2.9.2 Anti-depressant Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 TAKEDA PHARMACEUTICAL INC.
2.10.1 Business Overview
2.10.2 Anti-depressant Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 TAKEDA PHARMACEUTICAL INC. Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-depressant Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-depressant Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-depressant Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-depressant Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-depressant Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-depressant Drugs Market Analysis by Regions
4.1 Global Anti-depressant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-depressant Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-depressant Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-depressant Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Anti-depressant Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-depressant Drugs Sales and Growth Rate (2013-2018)
4.5 South America Anti-depressant Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-depressant Drugs Sales and Growth Rate (2013-2018)
5 North America Anti-depressant Drugs by Countries
5.1 North America Anti-depressant Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-depressant Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-depressant Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-depressant Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Anti-depressant Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-depressant Drugs Sales and Growth Rate (2013-2018)
6 Europe Anti-depressant Drugs by Countries
6.1 Europe Anti-depressant Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-depressant Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-depressant Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-depressant Drugs Sales and Growth Rate (2013-2018)
6.3 UK Anti-depressant Drugs Sales and Growth Rate (2013-2018)
6.4 France Anti-depressant Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Anti-depressant Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Anti-depressant Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-depressant Drugs by Countries
7.1 Asia-Pacific Anti-depressant Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-depressant Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-depressant Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-depressant Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Anti-depressant Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Anti-depressant Drugs Sales and Growth Rate (2013-2018)
7.5 India Anti-depressant Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-depressant Drugs Sales and Growth Rate (2013-2018)
8 South America Anti-depressant Drugs by Countries
8.1 South America Anti-depressant Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-depressant Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-depressant Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-depressant Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-depressant Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-depressant Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-depressant Drugs by Countries
9.1 Middle East and Africa Anti-depressant Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-depressant Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-depressant Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-depressant Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Anti-depressant Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-depressant Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-depressant Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-depressant Drugs Sales and Growth Rate (2013-2018)
10 Global Anti-depressant Drugs Market Segment by Type
10.1 Global Anti-depressant Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-depressant Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-depressant Drugs Revenue and Market Share by Type (2013-2018)
10.2 Tricyclic Antidepressants Sales Growth and Price
10.2.1 Global Tricyclic Antidepressants Sales Growth (2013-2018)
10.2.2 Global Tricyclic Antidepressants Price (2013-2018)
10.3 Selective Serotonin Reuptake Inhibitors Sales Growth and Price
10.3.1 Global Selective Serotonin Reuptake Inhibitors Sales Growth (2013-2018)
10.3.2 Global Selective Serotonin Reuptake Inhibitors Price (2013-2018)
10.4 Serotonin-Norepinephrine Reuptake Inhibitors Sales Growth and Price
10.4.1 Global Serotonin-Norepinephrine Reuptake Inhibitors Sales Growth (2013-2018)
10.4.2 Global Serotonin-Norepinephrine Reuptake Inhibitors Price (2013-2018)
10.5 Monoamine Oxidase Inhibitors Sales Growth and Price
10.5.1 Global Monoamine Oxidase Inhibitors Sales Growth (2013-2018)
10.5.2 Global Monoamine Oxidase Inhibitors Price (2013-2018)
10.6 Serotonin Antagonist Sales Growth and Price
10.6.1 Global Serotonin Antagonist Sales Growth (2013-2018)
10.6.2 Global Serotonin Antagonist Price (2013-2018)
10.7 Reuptake Inhibitors Sales Growth and Price
10.7.1 Global Reuptake Inhibitors Sales Growth (2013-2018)
10.7.2 Global Reuptake Inhibitors Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Anti-depressant Drugs Market Segment by Application
11.1 Global Anti-depressant Drugs Sales Market Share by Application (2013-2018)
11.2 Major Depressive Disorder Sales Growth (2013-2018)
11.3 Obsessive-Compulsive Disorder Sales Growth (2013-2018)
11.4 Generalized Anxiety Disorder Sales Growth (2013-2018)
11.5 Panic Disorder Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Anti-depressant Drugs Market Forecast (2018-2023)
12.1 Global Anti-depressant Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-depressant Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-depressant Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-depressant Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-depressant Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-depressant Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-depressant Drugs Market Forecast (2018-2023)
12.3 Anti-depressant Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-depressant Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-depressant Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-depressant Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-depressant Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-depressant Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-depressant Drugs Picture
Table Product Specifications of Anti-depressant Drugs
Figure Global Sales Market Share of Anti-depressant Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
